The Lancet is an esteemed healthcare and internet company based in the United Kingdom. Founded in 1823 by Thomas Wakley, it began as an independent, international weekly general medical journal. The company's slogan "The best science for better lives" reflects its core mission of making science widely available to positively impact society and people's lives. For over two centuries, The Lancet has been dedicated to addressing urgent societal issues, sparking debates, contextualizing science, and influencing decision makers globally. Although it has evolved into a family of journals, the company maintains its fundamental belief that medicine and knowledge should serve and transform society, and that exemplary science should lead to improved lives. As of now, there is no public information available regarding the last investment or the involved investors. However, given the company's rich history and substantial impact in the healthcare and scientific community, The Lancet continues to be a significant player in the industry striving to uphold its mission to leverage science for the betterment of society.
There is no investment information
No recent news or press coverage available for The Lancet.